Articles tagged with Probiotics
Researchers found that a strain of probiotic bacteria can alter its coat to outcompete harmful bacteria. This ability may prevent the growth of Clostridium perfringens in poultry, reducing the risk of necrotic enteritis and food poisoning.
A University of Michigan study reveals that probiotics can reverse the effect of stress on gut microbiota, reducing inflammation and alleviating symptoms of irritable bowel syndrome. The study also highlights the importance of maintaining a healthy gut microbiome through lifestyle changes.
Scientists at Michigan State University found that a natural probiotic supplement can enhance bone density in male mice, but not female mice. The study suggests a possible new treatment for osteoporosis without the risks of traditional medications.
A new study found that chemicals secreted by good bacteria can reduce the frequency and severity of necrotizing enterocolitis (NEC) in premature infants. The treatment, which uses purified secretions from probiotic bacteria, shows promise as a targeted preventive strategy without the broad effects of steroids.
Researchers found that probiotic supplementation improved gastrointestinal immune function and decreased inflammation in SIV-infected macaques treated with ARV. These findings suggest that probiotics could benefit ARV-treated HIV patients, potentially leading to better treatment outcomes.
Researchers found that probiotic supplementation improved gastrointestinal immune function and reduced inflammation in SIV-infected macaques, a model for human HIV-infection. This study suggests that probiotics could benefit ARV-treated HIV patients by mitigating the damage caused by viral-induced gut inflammation.
A new study found that feeding probiotics to baby zebrafish accelerated their development and increased their chances of survival into adulthood. The researchers discovered that the probiotics helped promote growth, including bone and vertebrae development, by reducing stress on the fish's gastrointestinal tract.
Researchers found that prophylactic use of probiotics significantly reduces the incidence of Clostridium difficile-associated diarrhea (CDAD) in adults and children taking antibiotics. In contrast, epidural corticosteroid injections offer only short-term relief from sciatica pain and disability for patients with this condition.
A study found that adding the prebiotic fructooligosacharide (FOS) to the diets of pediatric patients with intestinal failure can increase gut growth and function. The prebiotic converts into butyrate, a short-chain fatty acid that enhances nutrient digestion and absorption.
A survey of 677 supplement users found that nearly half are concerned about heart health and 75% prefer natural ways to lower cholesterol. The new probiotic supplement Cardioviva aims to fill this gap with a safe and natural addition to a heart-healthy diet and lifestyle.
Researchers are developing new prebiotic ingredients to support the growth of beneficial gut bacteria. Studies show that consuming more prebiotics can improve gut balance and lead to various health benefits, particularly for individuals with gastrointestinal diseases, Type-2 diabetes, and low-grade inflammation.
Combining VSL#3 with traditional therapies increases remission rates by 10-17% and initiates remission 47-69% faster. This combination is also more effective than using anti-inflammatory drugs alone.
A Category Tree system would categorize products based on tested human studies and health benefits, forcing companies to conduct research or change product labels. This system aims to improve transparency and facilitate further research in North America and Europe.
Studies show that statin therapy may be safe and beneficial for individuals with cirrhosis, reducing heart disease risk. Additionally, adding telaprevir to a drug regimen improves quality of life in patients with chronic hepatitis C. Probiotic dairy consumption also affects brain regions controlling emotional arousal.
A review and meta-analysis of previous studies found that probiotic consumption is associated with a reduced risk of antibiotic-associated diarrhea. The study analyzed 82 randomized controlled trials involving 11,811 participants, finding a 42% lower risk of developing diarrhea with probiotic use.
A RAND Corporation study found that taking probiotics can significantly reduce the risk of developing diarrhea caused by antibiotics. The study, which pooled data from over 100 research studies, showed a 42% lower risk of antibiotic-associated diarrhea with probiotic use.
Researchers have developed a model gastric system to evaluate probiotic survival, finding that some bacteria strains thrive in fermented milks. The study suggests that certain lactococcal and enterococci strains can resurrect their viability in the small intestine.
Sigma-Tau Pharmaceuticals is sponsoring a Patient Assistance Program (PAP) to provide financial assistance for VSL#3 DS, a prescription-only double strength probiotic formulation, to eligible patients with ulcerative colitis or ileal pouch. The program aims to make it easier for those in need to access the probiotic medical food.
Researchers at NOAA's Milford Laboratory have isolated a new probiotic bacterium, OY15, that significantly improves larval survival in oyster hatcheries. The study confirms the protective effect of naturally-occurring probiotic bacteria against bacterial disease and promotes healthy growth.
Research published in the FASEB Journal reveals that intestinal microbiota play a crucial role in determining the outcome of heart attacks in rats. The study found that probiotics can tilt the scales in favor of improved cardiovascular health, reducing heart attack risk and improving recovery from myocardial infarction.
Researchers have found that adding a specific protein from Listeria to a probiotic can decrease the risk of infection by 46%. The breakthrough could lead to the development of a pill or drink to prevent Listeria infections, primarily affecting pregnant women and those with weakened immune systems.
Researchers found that probiotic treatment increased interferon levels and reduced the number of infections in ICU patients. Probiotics also helped to shift the balance of the immune system, reducing Th2-associated factors and promoting a healthier response.
Researchers found that taking a probiotic before radiation therapy can protect the intestine from damage in mice, and may help prevent similar problems in human patients. The probiotic Lactobacillus rhamnosus GG protected the lining of the small intestine in mice exposed to radiation.
Researchers found that probiotics significantly reduce the incidence of antibiotic-associated diarrhea and Clostridium difficile-associated diarrhea. Probiotic therapy has been shown to be effective in treating various GI conditions, including ulcerative colitis, psoriasis, and chronic fatigue syndrome.
Researchers at the University of Bristol identified a probiotic strain that can thrive in high-iron environments and reduce inflammation associated with IBD. The discovery offers hope for developing novel treatments for active intestinal disease.
Researchers have developed a special type of biopolymer that protects probiotic bacteria from the acidic stomach environment and delivers them safely to the intestines. This innovation could lead to better quality probiotic food products and increase calcium absorption, benefiting gut health and bone structure.
Probiotic bacteria have limitations in conventional production processes. Researchers at TUM developed a gentle method using low-temperature vacuum drying, which is energy and cost-efficient. This process improves storage stability, allowing more active bacteria to remain in products until consumption.
Researchers propose a new field of microbial endocrinology linking probiotics to neurological function. Studies show that neurochemicals produced by gut microbes can influence behavior and immune response. Probiotic intestinal microbiota may deliver beneficial effects through direct uptake from the gut.
A study by Caroline Karlsson found that rats fed a specific lactic acid bacteria HEAL19 had significantly less weight and inflammation compared to those without the bacteria. Additionally, babies born vaginally have lactobacilli in their gut flora as early as two days after birth.
Researchers identified a new probiotic bacteria-derived soluble protein that provides therapeutic protection against intestinal inflammation. The protein, p40, was delivered to the colon and protected mice from colitis through an EGFR-dependent mechanism.
A new probiotic treatment has been shown to reduce the rate of recurrent urinary tract infections in women. The study found that women who received a Lactobacillus crispatus intravaginal suppository had lower infection rates compared to those who received a placebo.
Research suggests that probiotic E. coli Nissle 1917 can reduce negative effects of AIEC in Crohn's patients, modulating inflammatory immune proteins. The study emphasizes the potential of EcN in IBD treatment and its use as a therapeutic option for CD patients with pathogenic AIEC.
A strain of probiotic bacteria, Bifidobacterium bifidum CECT 7366, has been identified as effective in treating ulcers caused by Helicobacter pylori. The probiotic strain demonstrated significant inhibition levels against H. pylori and partially relieved damage to gastric tissue.
A genetically tweaked probiotic has nearly eliminated colon inflammation in mice with colitis, halting disease progression by 95%. The novel probiotic strain may prove useful in colon cancer, another disease triggered by inflammation.
Specially designed probiotics can modulate host fat cells, potentially leading to specialized probiotics for obesity prevention or treatment. Ingesting live bacteria influences metabolism at remote sites in the body.
A systematic review found that probiotics shortened diarrhoea episodes by around a day and reduced the risk of prolonged episodes by 59% in patients with diarrhoeal diseases. No serious adverse effects were reported.
A randomized, double-blind study found that mothers who consumed probiotic milk during and after pregnancy had a 40% lower incidence of eczema in their children. The study suggests that the probiotic bacteria may have prevented the development of eczema, with less severe cases in children who did develop eczema.
A new study found that daily use of probiotics reduced VAP infections by almost half and decreased antibiotic consumption, leading to fewer Clostridium difficile infections. The probiotic therapy was found to be safe with no side effects.
The study found a 19 percent decrease in common infections among children who drank DanActive, with specific reductions in gastrointestinal and upper respiratory tract infections. However, the reduction did not result in fewer missed school days or activities.
Daily probiotic cheese consumption boosts natural and acquired immunity in older adults by activating NK blood cells and increasing phagocytic activity. The study aims to thwart immunosenescence, an age-related deterioration of the immune system that increases susceptibility to infections and cancer.
A probiotic strain, B. lactis HN019, attenuates IL-8 mRNA level and reduces pro-inflammatory responses in intestinal epithelial cells. It also internalizes into cells and excludes enteropathogen adhesion, contributing to homeostasis of the intestinal epithelium.
A randomized, controlled study found that probiotics supplemented in enteral feedings of extremely low birthweight infants (ELBW) led to better weight gain compared to those without supplementation. No adverse effects were reported.
A meta-analysis published in the World Journal of Gastroenterology suggests that probiotics are an auxiliary medicine for inducing and maintaining remission in ulcerative colitis. The study concluded that probiotics should be considered as a treatment option for this chronic disease.
A new thesis at the University of Gothenburg reveals that a probiotic, Lactobacillus plantarum, has no effect on Salmonella bacteria. Researchers found that the probiotic did not reduce diarrhoea or shorten the duration of infection in patients with Salmonella.
Research published in World Journal of Gastroenterology found that fermented milk with Streptococcus thermophilus CRL 1190 exhibited therapeutic effects on chronic gastritis, particularly by modulating the immune response and increasing the thickness of the gastric mucus gel layer. This natural alternative may offer a potential treatme...
Hypnotherapy has been shown to significantly improve irritable bowel syndrome (IBS) symptoms in a majority of cases, with some patients experiencing complete relief. Probiotics can also be an effective option, but the efficacy depends on specific strains and clinical trial evidence.
Recent studies have identified probiotic microbes that produce anti-inflammatory compounds, such as butyric acid, which may treat inflammatory bowel disease. Strains like Faecalibacterium prausnitzii and Butyricicoccus pullicaecorum have shown promise in restoring normal gut bacteria levels and alleviating symptoms.
A study of mucosal biopsies from patients with ileal pouch-anal anastomosis reveals protein expression changes in pouchitis and antibiotic-induced remission. Proteomic analysis identifies novel biomarkers for disease activity, diagnosis, and prognosis.
A probiotic bacterium, Bacillus polyfermenticus, has been shown to effectively treat colitis in mice by promoting the growth of new blood vessels. The study found that the bacteria increased angiogenesis, a process necessary for wound healing, and reduced inflammation in affected tissues.
Researchers from the University of Helsinki have shed light on the origin of probiotic mechanisms, promoting product development in the food industry. The study found that LGG probiotics have a fundamental role in binding with human intestinal mucus, enabling health-promoting effects.
A clinical trial of kefir in young children using antibiotics found no benefit in preventing diarrhea. However, the study suggests that kefir may help healthier children, and more research is needed to confirm this finding.
A study published in the Journal of Gastrointestinal Surgery found that taking probiotics after Roux-en-Y gastric bypass surgery can help obese patients shed more pounds. Probiotics also helped improve levels of vitamin B-12, which are often deficient after gastric-bypass surgery.
A randomized controlled trial found that adding probiotics to conventional high-energy ready-to-use therapeutic foods did not improve nutritional cure rates or reduce mortality in severely malnourished African children. However, the study suggests a possible observation of reduced outpatient mortality in HIV-positive children.
A new study found that taking probiotics during pregnancy can help reduce the risk of obesity in women, particularly central obesity and body fat percentage. The study involved 256 pregnant women who received either dietary counselling alone or with daily capsules of probiotics containing Lactobacillus and Bifidobacterium.
Researchers used probiotics to protect animals from diseases such as mastitis and salmonellosis, demonstrating their potential to prevent and treat human diseases. The study identified specific bacterial species and mechanisms of action that could lead to the development of new treatments.
A researcher at Northwestern University has developed a new oral vaccine using probiotics that induces a powerful immune response, protecting against diseases such as anthrax and breast cancer. The vaccine harnesses the body's primary immune force in the small intestine, bypassing traditional injection methods.
Researchers found that four strains of probiotics, including E.faecalis, alleviated symptoms of experimental colitis in mice. The study suggests that different probiotics have varying effects on the condition, with E_faecalis showing superior benefits.
Researchers found that applying a probiotic bacterial solution in place of antiseptics effectively prevents respiratory illness in ventilated patients. The friendly bacteria, Lactobacillus plantarum 299, has no negative side effects and does not contribute to antibiotic-resistant strains.
Several new studies suggest that probiotics can help improve symptoms of Irritable Bowel Syndrome (IBS), including constipation or diarrhea. The research findings indicate that probiotics may be effective in normalizing bowel movement frequency, reducing IBS-related symptoms such as abdominal pain and bloating.
Researchers found that probiotic bacteria can efficiently mature monocyte-derived dendritic cells, leading to the production of specific cytokines. The maturation process was triggered by different bacterial strains, with some inducing pro-inflammatory and others anti-inflammatory responses.